| Symbol |
Name |
|
AAAS
|
achalasia, adrenocortical insufficiency, alacrimia
|
|
ACOT13
|
acyl-CoA thioesterase 13
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADM2
|
adrenomedullin 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
AMOT
|
angiomotin
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L10
|
BCL2-like 10 (apoptosis facilitator)
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BYSL
|
bystin-like
|
|
C3
|
complement component 3
|
|
CAT
|
catalase
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CDC25C
|
cell division cycle 25C
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CKB
|
creatine kinase, brain
|
|
CLDN4
|
claudin 4
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DDX11
|
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
EDN1
|
endothelin 1
|
|
EFNA1
|
ephrin-A1
|
|
EGF
|
epidermal growth factor
|
|
EIF2B4
|
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EPO
|
erythropoietin
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FAS
|
Fas cell surface death receptor
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF9
|
fibroblast growth factor 9
|
|
FHL1
|
four and a half LIM domains 1
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase)
|
|
GATA2
|
GATA binding protein 2
|
|
GDF9
|
growth differentiation factor 9
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX3
|
glutathione peroxidase 3
|
|
GPX4
|
glutathione peroxidase 4
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HK2
|
hexokinase 2
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HOXA10
|
homeobox A10
|
|
HOXD13
|
homeobox D13
|
|
HPSE
|
heparanase
|
|
HPSE2
|
heparanase 2 (inactive)
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IL11
|
interleukin 11
|
|
IL13
|
interleukin 13
|
|
IL18
|
interleukin 18
|
|
IL4
|
interleukin 4
|
|
INADL
|
InaD-like (Drosophila)
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JUN
|
jun proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ1OT1
|
KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
|
|
KCTD15
|
potassium channel tetramerization domain containing 15
|
|
KITLG
|
KIT ligand
|
|
KRT79
|
keratin 79, type II
|
|
LEFTY1
|
left-right determination factor 1
|
|
LEFTY2
|
left-right determination factor 2
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LIF
|
leukemia inhibitory factor
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MESP2
|
mesoderm posterior basic helix-loop-helix transcription factor 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP26
|
matrix metallopeptidase 26
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NAT9
|
N-acetyltransferase 9 (GCN5-related, putative)
|
|
NEO1
|
neogenin 1
|
|
NEUROG2
|
neurogenin 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH2
|
notch 2
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
OLFM1
|
olfactomedin 1
|
|
OVGP1
|
oviductal glycoprotein 1, 120kDa
|
|
PABPN1L
|
poly(A) binding protein, nuclear 1-like (cytoplasmic)
|
|
PAX3
|
paired box 3
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
|
PCTP
|
phosphatidylcholine transfer protein
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PFKM
|
phosphofructokinase, muscle
|
|
PGR
|
progesterone receptor
|
|
PGRMC1
|
progesterone receptor membrane component 1
|
|
PHB2
|
prohibitin 2
|
|
PLCZ1
|
phospholipase C, zeta 1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRM1
|
protamine 1
|
|
PRM2
|
protamine 2
|
|
PRNP
|
prion protein
|
|
PROK1
|
prokineticin 1
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PTX3
|
pentraxin 3, long
|
|
PURA
|
purine-rich element binding protein A
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RB1
|
retinoblastoma 1
|
|
RHOA
|
ras homolog family member A
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100A11
|
S100 calcium binding protein A11
|
|
S100P
|
S100 calcium binding protein P
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SELL
|
selectin L
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SLC22A25
|
solute carrier family 22, member 25
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SMAD6
|
SMAD family member 6
|
|
SOX13
|
SRY (sex determining region Y)-box 13
|
|
SPP1
|
secreted phosphoprotein 1
|
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13
|
|
TBX3
|
T-box 3
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TGM2
|
transglutaminase 2
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TP53
|
tumor protein p53
|
|
TRO
|
trophinin
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
WT1
|
Wilms tumor 1
|
|
WTIP
|
Wilms tumor 1 interacting protein
|
|
XDH
|
xanthine dehydrogenase
|
|
ZNF43
|
zinc finger protein 43
|
